Published in Proc Natl Acad Sci U S A on June 15, 1991
Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J (1996) 3.09
Phospholipase A2 activating protein and idiopathic inflammatory bowel disease. Gut (1996) 1.48
Membrane tubule-mediated reassembly and maintenance of the Golgi complex is disrupted by phospholipase A2 antagonists. Mol Biol Cell (1999) 1.33
The cytotoxic enterotoxin of Aeromonas hydrophila induces proinflammatory cytokine production and activates arachidonic acid metabolism in macrophages. Infect Immun (2000) 1.21
An Armadillo motif in Ufd3 interacts with Cdc48 and is involved in ubiquitin homeostasis and protein degradation. Proc Natl Acad Sci U S A (2009) 1.06
Role of Doa1 in the Saccharomyces cerevisiae DNA damage response. Mol Cell Biol (2006) 1.04
Lub1 participates in ubiquitin homeostasis and stress response via maintenance of cellular ubiquitin contents in fission yeast. Mol Cell Biol (2004) 1.04
Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J (1999) 1.04
Dehydration, rehydration, and overhydration alter patterns of gene expression in the Antarctic midge, Belgica antarctica. J Comp Physiol B (2009) 1.00
Molecular genetic analysis of volatile-anesthetic action. Mol Cell Biol (1996) 0.96
miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology (2012) 0.96
Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J Clin Invest (1994) 0.90
Structure and function of the PLAA/Ufd3-p97/Cdc48 complex. J Biol Chem (2009) 0.86
Cholera toxin induces synthesis of phospholipase A2-activating protein. Infect Immun (1996) 0.83
Role of cytosolic calcium-independent plasmalogen-selective phospholipase A2 in hypoxic injury to rabbit proximal tubules. J Clin Invest (1994) 0.82
Role of cyclooxygenase enzymes in a murine model of experimental cholera. Infect Immun (2003) 0.78
Phospholipase A2 secretion during intestinal graft ischemia. Dig Dis Sci (1997) 0.78
Ca(2+)-independent arachidonic acid release by vascular endothelium requires protein synthesis de novo. Biochem J (1994) 0.77
Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA). Cell Signal (2008) 0.76
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75
Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol (1980) 61.16
A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Efficient isolation of genes by using antibody probes. Proc Natl Acad Sci U S A (1983) 34.00
High efficiency DNA-mediated transformation of primate cells. Science (1983) 8.09
Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A (1986) 5.18
Regulation of metallothionein--thymidine kinase fusion plasmids injected into mouse eggs. Nature (1982) 5.14
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc Natl Acad Sci U S A (1986) 4.92
A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature (1987) 4.85
The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem Pharmacol (1976) 3.88
Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A (1979) 3.48
Intracellular phospholipases A. Biochim Biophys Acta (1980) 3.29
Lambda gt 11: gene isolation with antibody probes and other applications. Methods Enzymol (1987) 3.17
Phospholipase A2 and phospholipase C are activated by distinct GTP-binding proteins in response to alpha 1-adrenergic stimulation in FRTL5 thyroid cells. Proc Natl Acad Sci U S A (1986) 2.45
Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2. Proc Natl Acad Sci U S A (1987) 2.17
Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol (1986) 1.47
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J (1988) 1.42
Activation of high levels of endogenous phospholipase A2 in cultured cells. Proc Natl Acad Sci U S A (1979) 1.37
Facilitation of phospholipase A2 activity by mastoparans, a new class of mast cell degranulating peptides from wasp venom. J Biol Chem (1983) 1.31
Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem (1990) 1.30
Identification and isolation of a mammalian protein which is antigenically and functionally related to the phospholipase A2 stimulatory peptide melittin. J Biol Chem (1987) 1.26
Evidence for sequential signals in the induction of the arachidonic acid cascade in macrophages. J Exp Med (1986) 1.17
Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem (1986) 1.17
Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin secretion. J Biol Chem (1979) 1.12
Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3. Requirement for protein synthesis. J Biol Chem (1977) 1.10
Approaches to the study of mammalian cellular phospholipases. J Lipid Res (1985) 1.02
Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem Biophys Res Commun (1981) 1.01
Effect of leukotrienes, bradykinin and calcium ionophore (A 23187) on bovine endothelial cells: release of prostacyclin. Prostaglandins (1986) 1.00
Islet-activating protein inhibits leukotriene D4- and leukotriene C4- but not bradykinin- or calcium ionophore-induced prostacyclin synthesis in bovine endothelial cells. Proc Natl Acad Sci U S A (1986) 1.00
Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J Lab Clin Med (1990) 0.94
A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. J Immunol (1989) 0.93
Monosodium urate crystals stimulate phospholipase A2 enzyme activities and the synthesis of a phospholipase A2-activating protein. J Immunol (1990) 0.93
The binding of leukotriene C4 and leukotriene D4 to membranes of a smooth muscle cell line (BC3H1) and evidence that leukotriene induced contraction in these cells is mediated by thromboxane, protein and RNA syntheses. Eur J Pharmacol (1985) 0.87
Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol Cell Biol (1994) 3.27
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem (2000) 2.88
Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry (1989) 2.26
Mitomycin C: a review. Cancer Treat Rev (1976) 1.92
Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84
Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis. Scand J Rheumatol (1996) 1.70
Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature (1988) 1.68
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem (1987) 1.66
Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev (1979) 1.60
Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood (1987) 1.60
Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci U S A (1989) 1.58
Properties of cloned and expressed human RNase H1. J Biol Chem (1999) 1.52
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J (1988) 1.42
Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res (1992) 1.39
Comprehensive reform of the new drug regulatory process. Biotechnology (N Y) (1995) 1.38
Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells. Mol Pharmacol (1988) 1.35
Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci U S A (1989) 1.30
Cloning and expression of a yeast copper metallothionein gene. Gene (1984) 1.30
Yeast metallothionein function in metal ion detoxification. J Biol Chem (1986) 1.28
Bleomycin, a review. J Med (1976) 1.26
Identification and isolation of a mammalian protein which is antigenically and functionally related to the phospholipase A2 stimulatory peptide melittin. J Biol Chem (1987) 1.26
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry (1997) 1.23
In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. J Pharmacol Exp Ther (1998) 1.20
In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II). Cancer Res (1982) 1.18
General internal medicine consultation. The last bridge. Arch Intern Med (1983) 1.17
Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem (1986) 1.17
Vitravene--another piece in the mosaic. Antisense Nucleic Acid Drug Dev (1998) 1.16
Ubiquitin-metallothionein fusion protein expression in yeast. A genetic approach for analysis of ubiquitin functions. J Biol Chem (1988) 1.15
Cleavage of single strand RNA adjacent to RNA-DNA duplex regions by Escherichia coli RNase H1. J Biol Chem (1997) 1.15
Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities. Mol Pharmacol (1986) 1.11
Investigating the structure of human RNase H1 by site-directed mutagenesis. J Biol Chem (2001) 1.09
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep (1980) 1.09
Purification and characterization of a phosphoinositide-specific phospholipase C from guinea pig uterus. Phosphorylation by protein kinase C in vivo. J Biol Chem (1987) 1.09
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res (1987) 1.09
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res (1985) 1.07
Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry. Proc Natl Acad Sci U S A (1999) 1.07
Gene synthesis, expression, and processing of human ubiquitin carboxyl extension proteins. J Biol Chem (1989) 1.07
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res (1979) 1.05
Enhanced phospholipase activity in peripheral blood monocytes from patients with rheumatoid arthritis. Arthritis Rheum (1986) 1.03
Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun (1986) 1.02
Interactions of 5-lipoxygenase with membranes: studies on the association of soluble enzyme with membranes and alterations in enzyme activity. Biochemistry (1988) 1.02
Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes. Mol Pharmacol (1987) 1.02
Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci (1986) 1.01
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des (1997) 1.01
Effect of leukotrienes, bradykinin and calcium ionophore (A 23187) on bovine endothelial cells: release of prostacyclin. Prostaglandins (1986) 1.00
Islet-activating protein inhibits leukotriene D4- and leukotriene C4- but not bradykinin- or calcium ionophore-induced prostacyclin synthesis in bovine endothelial cells. Proc Natl Acad Sci U S A (1986) 1.00
Leukotriene-induced hydrolysis of inositol lipids in guinea pig lung: mechanism of signal transduction for leukotriene-D4 receptors. Mol Pharmacol (1987) 0.99
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds. J Med Chem (1987) 0.99
Isolation and characterization of a cDNA clone encoding rat 5-lipoxygenase. J Biol Chem (1988) 0.98
Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. Biochem Biophys Res Commun (1983) 0.98
In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. J Pharmacol Exp Ther (1995) 0.97
Inferior vena cava interruption in the management of pulmonary embolism. Chest (1982) 0.97
Bleomycin and talisomycin sequence-specific strand scission of DNA: a mechanism of double-strand cleavage. Cancer Res (1982) 0.96
In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Cancer Res (1986) 0.95
The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity. J Biol Chem (1997) 0.94
Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration. Biochem Pharmacol (2001) 0.94
Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo. J Lab Clin Med (1990) 0.94
Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). Cancer Res (1983) 0.94
A spectroscopic investigation of the metal binding site of bleomycin A2. The Cu(II) and Zn(II) derivatives. Biochim Biophys Acta (1978) 0.94
Etoposide (VP-16-213). Cancer Treat Rev (1979) 0.93
Expression and accurate processing of yeast penta-ubiquitin in Escherichia coli. J Biol Chem (1987) 0.93
Combinatorial drug discovery: which methods will produce the greatest value? Biotechnology (N Y) (1995) 0.92
Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells. Biochem J (1993) 0.92
Bifunctional intercalation of antitumor antibiotics BBM-928A and echinomycin with deoxyribonucleic acid. Effects of intercalation on deoxyribonucleic acid degradative activity of bleomycin and phleomycin. Biochemistry (1982) 0.92
Identification and partial purification of human double strand RNase activity. A novel terminating mechanism for oligoribonucleotide antisense drugs. J Biol Chem (1998) 0.92
Differential effects of fluoride on adenylate cyclase activity and guanine nucleotide regulation of agonist high-affinity receptor binding. Biochem J (1988) 0.92
Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line. Mol Pharmacol (1987) 0.91
SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4. Mol Pharmacol (1987) 0.91
Interactions of a new antitumor antibiotic BBM-928A with deoxyribonucleic acid. Bifunctional intercalative binding studied by fluorometry and viscometry. Biochemistry (1980) 0.91
Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes. J Med Chem (1986) 0.91
Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin. Antimicrob Agents Chemother (1985) 0.91
Identification and characterization of leukotriene D4 receptors and signal transduction processes in rat basophilic leukemia cells. J Biol Chem (1987) 0.91
Ubiquitin function studied by disulfide engineering. J Biol Chem (1989) 0.91
DNA supercoiling, shortening, and induction of single-strand regions by cis-diamminedichloroplatinum(II). Cancer Res (1981) 0.90
In vitro and in vivo pharmacologic activities of antisense oligonucleotides. Anticancer Drug Des (1991) 0.90
Leukotriene D4 receptor-mediated hydrolysis of phosphoinositide and mobilization of calcium in sheep tracheal smooth muscle cells. J Pharmacol Exp Ther (1988) 0.90
The cellular pharmacology of auranofin. Semin Arthritis Rheum (1987) 0.90
Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int (1984) 0.90
Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides. Mol Pharmacol (1995) 0.90
Progress in evaluation of the potential of antisense technology. Antisense Res Dev (1994) 0.90
Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin. Biochemistry (1979) 0.89
Molecular cloning and expression of cDNA for human RNase H. Antisense Nucleic Acid Drug Dev (1998) 0.89
The chief medical residency in the 1980s. Am J Med (1983) 0.89
Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line. Mol Pharmacol (1987) 0.89
Maytansine. Cancer Treat Rev (1978) 0.89
Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4. J Pharmacol Exp Ther (1986) 0.88
Responses of purified phospholipases A2 to phospholipase A2 activating protein (PLAP) and melittin. Biochim Biophys Acta (1993) 0.88
Single-strand and double-strand deoxyribonucleic acid breaks produced by several bleomycin analogues. Biochemistry (1981) 0.87
Human RNases H. Methods Enzymol (2001) 0.87
The binding of leukotriene C4 and leukotriene D4 to membranes of a smooth muscle cell line (BC3H1) and evidence that leukotriene induced contraction in these cells is mediated by thromboxane, protein and RNA syntheses. Eur J Pharmacol (1985) 0.87
Viscometric and fluorometric studies of deoxyribonucleic acid interactions of several new anthracyclines. Biochemistry (1982) 0.87
Identification of specific binding sites for leukotriene C4 in human fetal lung. Prostaglandins (1984) 0.87
Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs. Cancer Res (1980) 0.87